Innovative prodrug delivers superior efficacy with improved druglike properties and safety profileCAMBRIDGE, MA / ACCESSWIRE / March 28, 2024 / SynDevRx, Inc., a pioneering clinicalstage biotechnology company based in Cambridge, Massachusetts, has achieved a significant milestone. The company is delighted to announce the publication of a peerreviewed research paper describing its optimized MetAP2... Lire le communiqué |